Molecular mechanism of tacrolimus in treatment of glomerulosclerosis by stabilizing CD2AP expression

Yu Shengyou; Ren Qi; Yu Li

doi:10.3969/j.issn.0253-9802.2019.10.004

Yu Shengyou,Ren Qi,Yu Li

JOURNAL OF NEW MEDICINE ›› 2019, Vol. 50 ›› Issue (10) : 739-742.

PDF(1415 KB)

JOURNAL OF NEW MEDICINE ›› 2019, Vol. 50 ›› Issue (10) : 739-742. DOI: 10.3969/j.issn.0253-9802.2019.10.004

Original Research

Molecular mechanism of tacrolimus in treatment of glomerulosclerosis by stabilizing CD2AP expression

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 50(10): 739-742 https://doi.org/10.3969/j.issn.0253-9802.2019.10.004

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(1415 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2019-03-29	2019-10-15
Issue Date
2019-10-10

Please choose a citation manager

Content to export